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Abstract
Background: MicroRNAs are increasingly being appreciated as critical players in human diseases, and questions
concerning the role of microRNAs arise in many areas of biomedical research. There are several manually curated
databases of microRNA-disease associations gathered from the biomedical literature; however, it is difficult for
curators of these databases to keep up with the explosion of publications in the microRNA-disease field. Moreover,
automated literature mining tools that assist manual curation of microRNA-disease associations currently capture
only one microRNA property (expression) in the context of one disease (cancer). Thus, there is a clear need to
develop more sophisticated automated literature mining tools that capture a variety of microRNA properties and
relations in the context of multiple diseases to provide researchers with fast access to the most recent published
information and to streamline and accelerate manual curation.
Methods: We have developed miRiaD (microRNAs in association with Disease), a text-mining tool that
automatically extracts associations between microRNAs and diseases from the literature. These associations are
often not directly linked, and the intermediate relations are often highly informative for the biomedical researcher.
Thus, miRiaD extracts the miR-disease pairs together with an explanation for their association. We also developed a
procedure that assigns scores to sentences, marking their informativeness, based on the microRNA-disease relation
observed within the sentence.
Results: miRiaD was applied to the entire Medline corpus, identifying 8301 PMIDs with miR-disease associations.
These abstracts and the miR-disease associations are available for browsing at http://biotm.cis.udel.edu/miRiaD. We
evaluated the recall and precision of miRiaD with respect to information of high interest to public microRNA-
disease database curators (expression and target gene associations), obtaining a recall of 88.46–90.78. When we
expanded the evaluation to include sentences with a wide range of microRNA-disease information that may be of
interest to biomedical researchers, miRiaD also performed very well with a F-score of 89.4. The informativeness
ranking of sentences was evaluated in terms of nDCG (0.977) and correlation metrics (0.678-0.727) when compared
to an annotator’s ranked list.
Conclusions: miRiaD, a high performance system that can capture a wide variety of microRNA-disease related
information, extends beyond the scope of existing microRNA-disease resources. It can be incorporated into manual
curation pipelines and serve as a resource for biomedical researchers interested in the role of microRNAs in disease.
In our ongoing work we are developing an improved miRiaD web interface that will facilitate complex queries
about microRNA-disease relationships, such as “In what diseases does microRNA regulation of apoptosis play a
role?” or “Is there overlap in the sets of genes targeted by microRNAs in different types of dementia?”.”
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Background
MicroRNAs (miRs) are a class of small non-coding RNAs
encoded in the genomes of animals, plants, and protozoa.
In general, miRs negatively regulate gene expression by
base pairing with sequences in the 3’-untranslated region
of mRNAs, which either inhibits their translation or trig-
gers their cleavage. Thousands of miRs have been identi-
fied in mammals, and they have been implicated in the
control of a wide range of biological processes [1].
miRs are increasingly being appreciated as critical
players in human disease. The role of miRs in cancer is
very well established, with a wealth of studies demonstrat-
ing the participation of miRs in multiple cancer-related
processes in diverse tissue types [2]. miRs have also been
linked to many other diseases, including cardiovascular
disease [3], diabetes [4], neurological disease [5] and liver
[6] and intestinal [7] disorders.
Although at a mechanistic level miRs influence disease
through their effects on the expression of their target
genes, in the scientific literature miRs are associated
with diseases through a variety of relationships. In some
cases, miRs are directly associated with the disease itself
or with a feature or outcome of the disease, such as ag-
gressiveness [8], invasiveness [9], or patient survival [10].
In other cases, miRs are identified as biomarkers [11] or
therapeutic targets [12] for a disease. miRs can also be
linked to biological processes that are, in turn, con-
nected to the disease. This category includes miR-gene
targeting events, as well as regulation of processes such
apoptosis [13], metastasis [14], or cholesterol transport
[15] by miRs. Finally, in some cases, it is the state of the
miR (e.g., over- or under-expression [16]) that is associ-
ated with the disease.
There are currently several high-quality databases
that capture miR-disease associations and some of the
above relations, including miR2Disease [17], miRCan-
cer [18] and the Human microRNA Disease Database
(HMDD; [19]). These resources are literature based
and support searches for miR or disease of interest.
miR2Disease and miRCancer provide information on
miR expression in disease, and miR2Disease addition-
ally covers miR target genes. HMDD documents miRs
that are potential biomarkers and provides several ana-
lysis tools, such as miR set enrichment analysis. miR2-
Disease and HMDD are manually curated; thus they
are limited by the time-consuming nature of manual
curation and have difficulty keeping up with the explo-
sion of publications in the miR-disease field. In 2014
alone, using the PubMed query “miRNA[TIAB] OR
microRNA[TIAB] OR miR[TIAB]”, we obtained around
5100 PubMed citations, which was a 120 % increase
compared to 2013 and a 160 % increase compared to
2012. Additionally, we identified 19,402 abstracts (as of
February 2015) that mention miRs and of these, we
estimate 15,171 abstracts also mention disease terms
(as detected by PubTator [20]).
Automated literature mining tools could help
streamline and accelerate the curation process as well
as provide researchers with fast access to the most re-
cent published information; however, currently, such
tools are limited and have not been widely adopted.
Most of the miR-related literature mining tools avail-
able focus on extraction of miR-target gene relations
without regard to disease, and rely on relatively simple
text mining techniques, such as co-occurrence of miR
and disease in the same sentence or abstract. These in-
clude miRSel [21] and the tools used by the miR-target
databases miRWalk [22], TarBase [23], and miRTarBase
[24]. miRCancer [18], is one of the few resources that
uses a rule-based system to identify disease-relevant
miR information in literature, but is limited to detect-
ing miR expression associations in cancer.
In this work, we present miRiaD (microRNAs in asso-
ciation with Disease), which automatically extracts from
the biomedical literature associations between miRs and
diseases together with any intermediate relations that
bridge the association, thereby capturing “myriad” ways in
which a miR can be associated with a disease. In general
miRiaD connects a miR or an “aspect” of a miR (e.g., dif-
ferential expression, methylated state) to a disease or a
disease “aspect” (e.g., outcome or therapy) through some
relations (e.g., involvement, regulation, is-a). For example,
miRiaD can extract a miR’s involvement in the outcome
of a disease, or its role as a biomarker or therapeutic target
for a disease. Additionally, miRiaD can extract the involve-
ment of a miR in some cellular process that is highly
related to a disease, thus (indirectly) linking the miR with
the disease. These links between a miR and a disease
through cellular processes or target gene, which we refer
to as “linking entity”, are often implicit but highly inform-
ative to researchers studying disease mechanisms. Our
previous work, STEM [25], extracted relations between
two entities, namely a miR and process/function terms.
miRiaD extends upon the previous work by allowing more
type of entities to be linked (e.g. disease with its outcome,
miR with a disease outcome etc.).
We have applied miRiaD to the entire set of Medline ab-
stracts, and we provide a web interface through which the
results can be searched using PubMed-like queries. Details
about our miR-disease association extraction approach are
presented in the Methods section; screenshots and details
about the interface are provided in the Results and Discus-
sion section. In conjunction with miRiaD, we developed a
procedure for ranking sentences containing miR and dis-
ease mentions according to their “informativeness,” which
we envision can be used in the future to guide how miR-
iaD results will be presented to the user. The details of this
approach are given in the Methods section.
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miRiaD was evaluated with two potential user commu-
nities—miR-disease database curators and biomedical re-
searchers–in mind. To address the needs of curators, the
recall and precision of miRiaD was evaluated with re-
spect miR-target and miR expression information, which
are the two types of information curated by miR2Di-
sease, the most comprehensive database for miR-disease
associations; this evaluations achieved recall results be-
tween 88.46–90.78 %. For biomedical researchers, who
are potentially interested in the full range of possible
connections between miRs and disease, we evaluated
miRiaD with respect to a variety of sentences in which
miRs and diseases co-occur, resulting in F-scores of
89.4 %. Finally, an evaluation of our informativeness
ranking system accomplished an nDCG of 0.9815, as
well as correlations of 0.678–0.727, when compared to
an annotator’s ranked list. Details about the experimen-
tal setup and the evaluations are given in the Results
and Discussion section.
Methods: Approach and Implementation
In developing the miRiaD system, we attempted to cap-
ture the variety of ways in which connections between a
miR and a disease are stated in text. Figure 1 schematic-
ally depicts these relationships. First, both miRs and dis-
eases are often associated with descriptive information
or properties, which we will collectively refer to as “as-
pects.” Examples of miR aspects include expression level
and state (e.g., hyper-methylated or mutated); examples
of disease aspects include outcome/stage, biomarker, or
therapy. For convenience, we will refer to a miR or its
aspects as a miR entity (e.g. mir-9, overexpressed mir-9,
hypermethylation of mir-9) and likewise refer to a dis-
ease or its aspects as a disease entity (e.g. gastric cancer,
biomarker for gastric cancer). In some sentences, a miR
entity may be directly related to a disease entity. In other
cases, a miR entity may regulate a target gene or be in-
volved in a biological process that is in turn implicitly
linked to a disease entity. Even more complex associa-
tions are possible; for example, a miR may regulate a
gene that is involved in a biological process that is ultim-
ately relevant to a disease. These relationships may be
expressed in text using a variety of phrases and not all
phrases are applicable to all types of relationships. An
association between a miR and a process or disease is
likely to be described using relations such as “involved
in” or “has a role in”, whereas an association between a
miR and biomarker is likely to be expressed using an
“is-a” relation. A formal description of the patterns,
the list of triggers and the types relations between the
different pairs is provided in Additional file 1.
miRiaD identifies specific relations (i) between a miR and
its aspect, (ii) between a disease and its aspect and (iii) be-
tween a miR entity and a disease entity. For example, in the
sentence “Downregulation of mir-26a is associated with
tumor metastasis in osteosarcoma.”, miRiaD will detect
the connection between mir-26a and its aspect, downregu-
lation; between the disease osteosarcoma and its aspect,
tumor metastasis; and between miR entity “miR-26a down-
regulation” and the disease entity of “tumor metastasis in
osteosarcoma”.
miRiaD also detects multi-step connections where the
connection between the miR entity and disease entity is
mediated through another entity or process. We call this
extra entity or process a linking entity. Consider the sen-
tence, “MicroRNA-9 promotes tumor metastasis via
repressing E-cadherin in esophageal squamous cell carcin-
oma.” Typically, as in this sentence, the miR entity regu-
lates or is involved with the linking entity (E-Cadherin).
This regulation in turn can be connected to the disease
Fig. 1 miR-disease associations extracted by miRiaD. miRs or their aspects (state or expression levels) can be directly associated with diseases or
disease aspects (outcome, stage, biomarker/therapy) through a variety of relations; association can also be bridged by a linking entity such as a
target gene or biological process
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entity (tumor metastasis of esophageal squamous cell
carcinoma). However, it is quite common for the connec-
tion between the linking entity and the disease entity to be
left unstated with an understanding of the implicit con-
nection requiring additional domain knowledge.
miRiaD currently extracts information from Medline
abstracts. After the abstracts are retrieved the abstract
text and title are extracted. The text is split into individ-
ual sentences using a tool developed in-house. miRiaD
extracts the connection between a miR and disease,
through the detection of the direct relations between
miR entities and disease entities, or through detection of
multiple relations involving linking entities. miRiaD uses
the presence of certain lexico-syntactic dependency
structures in a sentence to detect these semantic rela-
tions. Thus, the basic steps of the miRiaD system in-
clude (i) Detecting miR/disease entities and “linking
entities”; (ii) preliminary syntactic processing; (iii) identi-
fying syntactic dependencies between miRs and co-
occurring terms; and (iv) assigning semantic relations
between miRs and co-occurring terms. These steps are
described below and also shown in Fig. 2. Finally, we
also describe a method to score sentences based on their
informativeness in describing miR-disease connections.
Detecting miR/disease entities and linking entities
miR entity
A miR entity can be a miR in isolation or together with one
of its aspects (expression, mutation, methylation). Although
miRs are mentioned in text in a variety of ways (e.g., miR-1,
microRNA1, miRNA-1, let-1, etc.), they follow a well-
established naming convention. miR mentions consists of a
prefix (“miR”, “MIR, “miRNA”, “microRNA”) followed by a
unique identifying number, which is assigned based on se-
quence similarity. This number may be followed by a suffix
such as “-a”, “-1”, “-3p” or “-5p”, and/or a prefix that de-
notes the species may be included. miRiaD detects such
miR mentions by using simple regular expressions.
miR aspects usually describe the abundance or prop-
erties of a miR. We detect the former by searching for
noun phrases headed by trigger words such as “level”,
“expression” and “regulation” as well as their variants.
For the latter, we consider mutation terms such as
“mutation”, “variants” or “polymorphism” as well as
nominalized forms of common events such as “methy-
lation”. Of course these terms are only candidates to be
miR aspects and are treated as such only after we de-
tect their syntactic relation to a miR.
Disease entity
A disease entity can be disease in isolation or in combin-
ation with one of its aspects (diagnostic, treatment, out-
come). We detect disease mentions using Pubtator [20]
database, which includes disease mentions tagged in
Medline abstracts by DNorm [26]. The disease mentions
are normalized to Medic concept IDs. We process only
those abstracts which have a disease mention and thus
recall for disease mention detection is important for the
miRiaD system performance. The DNorm [26] system
reports a micro-averaged precision, recall and f-measure
of 0.803, 0.763 and 0.762.
We did some additional analysis for PubTator disease
detection by randomly selecting 200 abstracts from the
miR2Disease database and checking whether the disease
annotated by the miR2Disease curators was detected by
Pubtator. A miR2Disease abstract can be annotated with
a disease which is not mentioned in the abstract but
mentioned in the full length article. Thus we selected
only those miR2Disease abstracts where the annotated
disease either was mentioned in the title or the abstract.
While checking if the annotated disease matched one of
the disease mentions detected by Pubtator, we allowed for
synonym matches (breast cancer with breast carcinoma).
Pubtator picked the exact name, a synonym or part of the
annotated disease name in 100 % of the abstracts. How-
ever in ten cases, it picked only part of the name, despite
Fig. 2 miRiaD Pipeline. The steps of the miRiaD pipeline are illustrated with numbered grey blocks. External tools used throughout the pipeline
are shown in bold and italic font
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the fact that there was ample evidence of the full
name mention. For example, in a sentence that con-
tained the phrase “Oral Squamous Cell Carcinoma
(OSCC) ”, PubTator only detected Squamous Cell
Carcinoma.
Similar to miR aspect detection, we locate disease as-
pects by looking for certain trigger words or and their
textual variations. Commonly occurring disease aspect
terms include disease stage or “outcome” terms/phrases
like “clinical outcome”, “disease free survival (dfs)”, “over-
all survival (os)”, “metastasis”, “sensitivity”, “prognosis”,
“tumorgenicity”, “invasion”, and “progression”. Diagnosis-
related terms include “biomarker”, “marker”, “predictor”,
“profiler”, “prognostic”, “diagnosis”, “indicator”, and their
textual variations; and finally treatment-related triggers in-
cluding “therapeutic”, “treatment”, “target”, “therapy”, and
their textual variations. As with miR aspects, a candidate
phrase is considered to be a disease aspect only after the
syntactic dependency (as described later) with a disease
mention is established. Several examples of miR entities
(“let-7i” and “low miR-335 levels”) and disease entities
(“colorectal cancer metastasis”, “overall survival”, and “re-
lapse-free survival”) are highlighted in the following
sentence fragments: “let-7i is associated with colorectal
cancer metastasis” and “low miR-335 levels in EOC
were associated with shorter overall survival and relapse-
free survival”
Linking entity
Linking entities are cellular processes or target genes
through which the miRs association with the disease can
be explained. We use PubTator, which uses GenNorm
[27] to identify gene mentions in a sentence. In order to
detect cellular processes, we follow the method adopted
in eGIFT [28], which uses dictionary look-ups or mor-
phological derivatives e.g., terms/phrases with -sion,
−tion, −sis, −or, −er, −ment suffixes. Candidate linking
entity phrases are excluded if they are determined to be
a miR/disease aspect phrase. Additionally syntactic de-
pendency (as discussed later in this section) needs to be
established for the candidate phrase to be considered as
a linking phrase. In the sentence fragment “mir-320a
down-regulation mediates bladder carcinoma invasion
by targeting itgb3 the linking entity is highlighted.
Preliminary Syntactic Processing
The miRiaD approach attempts to identify a relation be-
tween a miR entity and a disease entity or linking entity
by first identifying syntactic dependencies between
phrases of that sentence. Two steps facilitate the detec-
tion of such syntactic dependencies: chunking and sim-
plification. Note, to reduce overhead for the chunking
and simplification step, we filter out sentences that do
not contain a miR or a disease mention. Chunking is the
task of identifying and grouping words in a sentence into
constituents (noun groups, verb groups etc.) called
“chunks”. Sentences are tagged with part-of-speech
(POS) tags using the Genia Tagger [29]. We further
chunk the words based on syntactically related POS tags
to form noun phrases (NPs), verb groups (VGs) and
prepositional phrases (PPs).
After chunking, we use iSimp [30], which simplifies a
variety of complex syntax structures in a sentence into a
relatively small number of simple patterns, thus facilitating
the identification of syntactic dependencies and relation
extraction. iSimp [30] identifies syntactic constructs, such
as appositives, relative and reduced relative clauses, con-
junctions, and parenthetical elements. These syntactic
constructs are used to form simple sentences from a com-
plex sentence. For example, consider the following
sentence:
We have profiled four miRNAs, miR-21, miR-210,
miR-155, and miR-196a, all implicated in the
development of pancreatic cancer with either proven
or predicted target genes involved in critical cancer-
associated cellular pathways. (PMID 19,723,895)
We illustrate here how miRiaD identifies the relation
between miR-21 and the disease entity “pancreatic can-
cer development”. Automatically detecting a relationship
between miR-21 and pancreatic cancer in this sentence
might be difficult by just trying to match basic patterns
and rules. Additional information of no immediate use
occurs between the two mentions, preventing the pat-
terns from detecting a relationship. However, by using
simplification constructs identified by iSimp, we can
generate a simple sentence from the original sentence
that states the relationship in a straightforward way:
“Mir-21 is implicated in the development of pancreatic
cancer.” iSimp tags the following syntactic constructs:
(i) A conjunction in the form of a list of elements
(“miR-21, miR-210, miR-155, and miR-196a”),
(ii) A conjunction (“proven or predicted”),
(iii)The appositive construct involving the two noun
phrases “four miRNAs” and “miR-21, miR-210,
miR-155, and miR-196a”,
(iv)The reduced relative clause “all implicated in the
development of pancreatic cancer with either proven
or predicted target genes”, which modifies the noun
phrase “four miRNAs”
(v)Another reduced relative clause “involved in critical
cancer-associated cellular pathways”, which modifies
the noun phrase “target genes”
Using constructs (i) and (iii) we can replace “four
miRNAs” by “miR-21” in the construct (iv) and thus
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generate “miR-21 is implicated in the development of
pancreatic cancer …”. Additional simplifications are
also generated for the remaining elements of the list
(miR-210, miR-155, or miR-196a). Note that the
chunking information is carried through when generat-
ing simplified sentences from iSimp constructs.
Identifying Syntactic Dependencies
miRiaD extends our previous system [25], which was built
to detect semantic relations, such “involvement”, “regula-
tion”, “state”, “attribute” and “association”, between miRs
and biological processes or functional aspects of miRs.. Like
STEM, to capture the above semantic relations we detect
these semantic relations via the detection of the following
lexico-syntactic dependencies. 1) agent-theme of predicate
(e.g., “miR-9 regulates cell proliferation”), and 2) noun
modification (e.g., “miR-1 overexpression”, “metastasis of
gastric cancer”). We detect these lexico-syntactic depend-
encies after chunking and sentence simplification.
Agent-theme of predicate
We are interested in extracting the relations of “involve-
ment” and “regulation” where a miR entity is the agent
and a process (for example) is the theme. These often
have a syntactic dependency counterpart (subject and
object of a verb). Consider the example sentence “miR-9
regulates cell proliferation”. Here the “regulation” rela-
tion is represented by the verb “regulate” and the agent
(mir-9) and theme (cell proliferation) are the subject and
object of this verb. Typically the predicates are simple
verbs, and the arguments are noun phrases appearing to
the left and to the right of the predicate if the clause is
in active voice. However, with the use of chunking, it is
possible to extract relationships from more complex
sentences as well. Consider the sentence “mir-9 is
known to directly regulate cell proliferation”. Notice by
chunking this sentence we will get two verb groups (“is
known” and “to directly regulate”). The predicate verb
(“regulate”) is the head verb of the second of the two
consecutive verb groups and thus the noun phrase be-
fore this predicate is still “miR-9”. In the sentence “ex-
pression of mir-9 regulates proliferation of U87 cells.”
the agent and the theme are not base noun phrases, but
are larger noun phrases that have attached prepositional
phrases, which are identified by chunking.
The voice of the predicate verb is important in deter-
mining the role of the arguments. For example, in the
sentence “apoptosis is regulated by miR-9”, “miR-9” is
the agent performing the action “regulates” and “apop-
tosis” is the theme being regulated. This is the reason
why, rather than using syntactic notions of subject and
object, we refer to more thematic notions of agent and
theme of a predicate, abstracting away from word order.
There are also cases in which the predicate is
expressed in a nominalized form. For example, consider
the fragment “miR-9 regulation of cell proliferation”,
where the predicate is the nominalized form of the verb
“regulates”. We extend our agent-theme extraction rules
to handle such cases by following the rules for
nominalization from iXtractR [31].
Predicates need not necessarily be single words. In the
sentence “miR-146a may play a role in cell prolifera-
tion”, the predicate spans multiple words. Phrases like,
“is crucial for”, “is important for”, “plays a role in” are
some examples of multi-word predicates that we con-
sider. We defer to the next part of this section for a dis-
cussion of the words and phrases that constitute the
predicates we are interested in.
In some sentences, an argument (agent/theme) can
be shared by two predicates. For example, consider the
sentence “miR-126 was able to inhibit laryngeal squa-
mous cell carcinoma partly by suppressing Camsap1
expression”. Here, “miR-126” is the agent for both “in-
hibit” and “suppressing” predicates. Because it is awk-
ward to mention the agent each time one of its
predicates is used, the agent is mentioned only once, in
the beginning, and omitted in the second case (i.e., for
the verb suppress). We call the cases in which the ar-
gument is omitted and inferred from an earlier men-
tion the “null-argument” agent-theme of predicate.
Sentences with null-arguments have clauses separated
by prepositions “to” + a simple verb, “via” or “through”
+ nominal form of a verb, or “by” + a verb ending in
“ing”. For example, “Tumor suppressive miR-1 in-
duces apoptosis through direct inhibition of SRSF9 in
bladder cancer” is a sentence containing a null-
argument after “through” + nominal form of a verb.
The null argument rules that identify the agent for the
second predicate were taken from RLIMS-P [32] and
iXtractR [31].
Our rules are limited to some simple patterns corre-
sponding to simple syntactic structures in order to be
precise. Sentence simplification allows us to handle more
complex cases without making the patterns more in-
volved. Consider the sentence “breast cancer metastasis
suppressor 1 up-regulates mir-146, which suppresses
breast cancer metastasis”, which contains a relative
clause. Without simplification our rules would incor-
rectly extract [which (agent), suppresses (predicate),
breast cancer metastasis (theme)]. iSimp detects the
relative clause and generates a simplified sentence “mir-
146 suppresses breast cancer metastasis”, thus enabling
us to extract the correct relation [miR-146 (agent), sup-
presses (predicate), breast cancer (theme)]. As discussed
in the pre-processing step the other simplification con-
structs which iSimp handles include appositives, con-
junctions, reduced relative clauses and parentheticals.
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Noun modification
We detect “state” or “attribute” relations that are in a
noun modification syntactic relationship. Consider the
subject noun phrase in the sentence “mir-21 overexpres-
sion is associated with glioblastoma”. The entity “miR-21”
acts a modifier of a noun, “overexpression”, which is a
nominalized form of a stative verb. In this case the head
modifier relation indicates the state of entity “miR-9”.
Additionally the head modifier dependency can be stated
with a prepositional attachment (e.g., metastasis of gastric
cancer). In this work, we only consider these two forms of
noun modification syntactic dependency.
Assigning Semantic Relations
Having captured the syntactic dependency structures, we
look at the predicate for the identification of the seman-
tic relation between a miR entity and a disease entity or
a linking entity. In our previous work we observed that
the semantic relations that frequently connect a miR en-
tity with a related term (disease entity or linking entity)
fall into several categories, namely “involvement”, “regu-
lation”, “is-a”, “association” “found-in” and “state”. Each
category encompasses a number of trigger words that are
commonly found in text. The predicate detected in the
pattern used to detect the syntactic dependency can be
used to assign the relation to the appropriate category. For
example, if the predicate found in the sentence is “is in-
volved” or “is implicated”, then the relation is categorized
as an “involvement” relation. As noted earlier, the verb
group containing the predicate can contain additional
words modifying the predicate (e.g., “directly targets” or
“was able to inhibit”). In these situations, the head of the
final verb group is used when matching the trigger words
(e.g., “targets” or “inhibit”). Example trigger words and
sentences are given below for each of the four categories.
Although trigger words are provided in present tense in
the examples below, the reader should assume all of their
textual variations (tense and nominalized forms).
Involvement relations
For detection of the “involvement” relation, we expect
the use of the agent-predicate-theme dependency struc-
ture. Further, we expect the miR entity and the disease
entity or a linking entity to be picked as the agent and
theme respectively. A range of words or multi-word trig-
gers can be used as the predicate including: is involved in,
is implicated in, is required for, is needed for, play a role
in, is necessary/sufficient/crucial/etc. for, is dependent on,
participates in, contributes to, influences, fosters, affects,
allows, initiates, etc. The main verbs in these triggers can
appear in different tense forms and the verb or noun can
be modified, as in the sentence “miR-21 may play a critical
role in chronic myelogenous leukemia”.
Regulation relations
Regulation relations are similar to involvement relations
except for the list of trigger words/phrases that can serve
in the predicate position. Based on our previous work,
the regulation trigger words we use include: regulates,
promotes, induces, elevates, targets, enhances, increases,
decreases, raises, up/down-regulates, modulates, causes,
results, interacts, blocks, mediates, etc. In this category,
we also encounter cases in which the predicate is
expressed in a nominalized form. An example sentence
is “restoration of mirna-143 (mir-143) regulates cox-2
and inhibits cell proliferation of pancreatic cancer cells”.
Here the association between the miR-143 and the dis-
ease “pancreatic cancer” is via two linking entities: gene
(cox-2) and cellular process (cell proliferation).
Association relations
To find sentences where a miR entity is associated with
a process, linking entity, a disease or a disease outcome,
we consider sentences with agent-predicate-theme de-
pendencies with the following trigger words or phrases:
“is associated with”, “correlated with”, “linked to”, etc.
For example, in the sentence “reduced circulating mir-150
levels are associated with poor survival in pulmonary ar-
terial hypertension.” a miR entity (expression of mir-150)
is linked to a disease entity (“poor survival” in pulmonary
arterial hypertension”).
Is-a relations
Relations that link two entities via the is_a relation are
normally of agent-predicate-theme type. We expect the
miR entity and the disease entity or linking entity to be
picked as the agent and theme respectively, with “be” as
trigger. However we include a wider range of trigger
words or phrases such as:. is, are, acts as, functions as,
serves as, etc. In the example sentence “Plasma miR-601
and miR-760 can potentially serve as promising non-
invasive biomarkers for the early detection of colorectal
cancer” both miR-601 and miR-760 are in a is_a relation
with “non_invasive biomarkers” as indicated by the trig-
ger phrase “serve as”. Note that sentence simplification
makes it possible to link both miR to the theme “non-in-
vasive biomarkers”.
Found_in
For detection of the “found_in” relation, we expect the
use of the agent-predicate-theme dependency structure.
Further, we expect the miR entity and the disease to be
picked as the agent and theme respectively. These rela-
tions indicate that an aspect of the miR (expression,
states like mutation, hyper-methylation) is found in the
disease. There are two classes of triggers used to detect
such relations. First set of triggers include words or
multi-word triggers like: “is found in”, “is detected in”,
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“is increased in” etc. In these cases the miR entity will in-
dicate the specific aspect of the miR (e.g. “high level of mir-
155 was found in gallbladder cancer”). In other cases the
aspect of the miR is inferred from the predicate trigger (e.g.
“miR-155 was overexpressed in gallbladder cancer”). The
triggers to detect such cases include: “overexpressed in”,
“highly expressed in”, “upregulated in”, “mutated in” etc..
State relations
These relations are used to describe relations between a
miR and its aspect or between disease and its aspect. In
these sentences, the term describes the state in which
the miR (or its promoter) is observed (e.g., overex-
pressed, methylated) or an outcome, treatment, or diag-
nostic property of the disease. Here we use the noun
modification syntactic dependency, where miR aspect or
disease aspect is the head noun and the miR or disease,
respectively, is the modifier. For miR aspects we use trig-
ger words such as methylation, expression, silencing, and
knockdown while for disease aspects we use words/
phrases such as level, biomarker, or disease free survival.
An example sentence is “Overexpression of the miR-200b
is associated with hepatocellular carcinoma cell migration
through the epithelial to mesenchymal transition”.
Multiple predicate triggers In some sentences there
may be multiple predicate triggers appearing between an
agent and a theme. For example in the sentence fragment
“miR-9 is involved in the regulation of apoptosis…”, the
two triggers “involved in” and “regulation” connect the
miR entity (mir-9) and the linking entity (apoptosis). In
such cases we can expect that one of the triggers will be
semantically more specific. Typically, we have found that
the more specific predicate is of the type “regulation” and
the more general predicate is of the type “is-a” or “involve-
ment”. Hence we modify the output to include only the
more specific relation. For example we first extract the
tuple [miR-9, is involved in, regulation of apoptosis] and
resolve it to [miR-9, regulates, apoptosis], categorizing it
as a “regulation” relation.
Assigning scores to sentences
As we have seen from the above sections, there are
many different ways in which a miR entity can be con-
nected to a disease entity in a sentence through various
linking entities and semantic relations. Biologists might
be interested in sentences containing some categories of
relation more than others, and might prefer sentences
mentioning certain types of semantic relations more
than others. We wanted to see if scoring sentences in
terms of linking entities, semantic relations, and other
factors (such as hedging), might help rank the sentences
in a specific way that is preferred by biologists. Such a
scoring system could potentially be used to prioritize the
most relevant sentences when presenting miRiaD results
to users.
Our assumption is that biologists might want to see
sentences mentioning a miR-disease relationship that is
explained via a target gene or a process. Equally import-
ant might also be sentences describing the miR-disease
relationship via a sequence of biological steps connected
by words such as “contributes”, “results in”, “causes”,
“supports” and their textual variations, as well as the
conjunction “and”. Less informative are sentences that
describe the miR-disease relationship in terms of expres-
sion level of the miR. We assign a score between 1 and
3 based on how informative the sentence is (highly in-
formative, informative, somewhat informative), using
empirically–derived rules.
Sentences are assigned to the highly informative
(3 points) category if they contain some explanation
of the connection between the miR and the disease.
We use two indicators for detecting the “explana-
tory” component. The first is the detection of null argu-
ment sentences. For example, in the sentence “miR-137
functions as a tumor suppressor by targeting CtBP1 to
inhibit epithelial-mesenchymal transition and inducing
apoptosis of melanoma cells” the target gene aspect of the
miR explains its functionality as a tumor suppressor. The
second indicator of the “explanatory” component is the
presence of at least two semantic relations, which form
a sequence of events/process/outcome/diagnostic/treat-
ment.. One such example is “Treatment of gastric cells
with dihydroartemisinin (DHA) increased miR-15b and
miR-16 expression, caused a downregulation of Bcl-2,
resulting in apoptosis of gastric cancer cells”. In
addition we also assign sentences to the highly inform-
ative category if they contain target gene information
together with some other relation (e.g., “UBASH3B is a
functional target of anti-invasive miR200a that is down-
regulated in triple negative breast cancer”).
Sentences are assigned to the informative (2 points)
category if they contain both diagnostic and treatment
disease aspects, a linking entity regulation process, or a
treatment aspect of a disease in the theme (e.g., miR is a
therapeutic target for a disease). Some example sen-
tences in this category include: “miR-23b is epigeneti-
cally down-regulated and restoration of miR-23b can
effectively suppress cell growth in glioma stem cells” or
“miR-139-5p is a potential biomarker for early diagnosis
and prognosis and is a therapeutic target for esophageal
squamous cell carcinoma (ESCC)”.
Sentences are assigned as somewhat informative
(1 point) if they contain an altered expression rela-
tion, an involvement relation, or a diagnostic aspect.
Some examples include: “High miR-199a expression
is associated with liver fibrosis” or “miR-125b could
be an important prognostic indicator for colorectal
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cancer patients”. All sentences that were not
assigned highly informative or informative scores are
also considered to be somewhat informative.
A sentence can be upgraded from “somewhat inform-
ative” to “informative” or “informative” to “highly in-
formative” if it contains an outcome aspect. A sentence
can also be downgraded if it contains a diagnostic/treat-
ment aspect that was obtained through a co-occurrence
relation (i.e., not part of the relation itself but co-
occurring in the sentence). Additionally, hedging or other
evidence of doubt will lower the score of the sentence by
one point. The triggers used here for doubt were “might”,
“could”, “suggest”, “propose”, and their lexical variations.
Evaluation: Overview and Experimental Setup
We evaluated miRiaD with respect to the needs of two po-
tential user communities: miR-disease database curators
and biomedical researchers studying disease mechanisms.
Study 1: Evaluation of miRiaD for assistance with manual
curation
Database curators can benefit from automated text min-
ing tools that make manual curation more efficient by
quickly identifying relevant information in the literature.
Because miR2Disease is the most comprehensive data-
base aiming to manually curate miR-disease relation-
ships, we focused our first study on the ability of
miRiaD to retrieve the types of information annotated
by miR2Disease, namely miR expression and target in-
formation in the context of disease. Initially, we tested
the recall of miRiaD using sentences from abstracts that
were cited as evidence in miR2Disease entries. By gath-
ering the evaluation set from the database itself, we are
guaranteed to have sentences that are of interest to
miR2Disease curators; however, because all of the sen-
tences are by definition positive, we cannot use them to
assess precision. Therefore, we also evaluated the recall
and precision miRiaD using a set of randomly selected
Medline abstracts not found in the miR2Disease database.
These abstracts were disease-focused and mentioned a
miR, but only a subset had target gene or miR expression
information, so we could test the ability of miRiaD to reject
papers that are not relevant for curation by miR2Disease.
We downloaded the entire mirRDisease database,
which contained 3273 entries at the time (January 2015).
Each entry in the downloaded file contained a miR, a
disease, a title of an article, and the year in which the
article was published. Because no PMIDs were provided
with the downloadable database, we looked up the
PMID corresponding to each entry by matching the title
and the year of publication in the Medline 2015 corpus.
We filtered out the entries for which the miR and the
disease mentions could not be found together in the ab-
stract or the title of the article. This resulted in a total of
486 entries in the miR2Disease database that we could
use for our study.
For these entries, we retrieved the title and the ab-
stract of each referenced article from the Medline 2015
corpus. We also obtained the descriptions accompanying
each miR-disease-article entry from the miR2Disease on-
line database. These descriptions consist of sentences
taken from the referenced article that support the miR-
gene relation in the entry. Because we have so far only
applied miRiaD to abstracts, we used Perl’s StringSimi-
larity Module, which is based on the algorithm described
in [33], followed by manual verification to detect entries
in which the description text was taken from the ab-
stract. Of these entries, we randomly chose 100 to test
the recall of the miRiaD system.
miR2Disease clearly mentions that their manual anno-
tations include miRNA expression patterns in the dis-
ease state, detection methods for miRNA expression,
and experimentally verified miRNA target gene(s).
Therefore, we manually reviewed each description, and
marked each sentence as containing expression and/or
target information. Ninety descriptions were marked as
containing expression information, and 58 descriptions
were marked as containing target information.
Next, we selected randomly selected 100 additional
Medline abstracts not found in the miR2Disease database.
The abstracts were selected to be focused on diseases (i.e.,
a disease is mentioned in the title, the first or the last sen-
tence of the abstract, or three or more times throughout
the abstracts, as defined in the work by Tudor et al. [28]).
One biologist annotator marked the abstracts in terms of
genes targeted by the miR and miR expression informa-
tion for the miR. There were 52 abstracts marked as con-
taining expression information and 48 abstracts marked
as containing target information.
Study 2: Evaluation for general extraction of miR-disease
associations
For our second study, we evaluated miRiaD with respect
to the extraction of a wide range of relations that appear
in text connecting a miR to a disease that may be of
interest to biomedical researchers. As above, we con-
ducted the study in two parts: first, we selected a set
which is highly likely to contain such relevant relation
between a miR entity and a disease or linking entity and
assessed recall and precision. Next we assessed precision
and recall of relations for randomly selected sentences
from Medline abstracts. For the first set, we gathered
Gene Reference into Function (GeneRIF) sentences from
the EntrezGene entries for miRs. GeneRIFs are used to
annotate EntrezGene entries and consist of short sen-
tences or phrases with literature citations describing the
function of the gene/miRNA [34]. These GeneRIF sen-
tences may or may not be direct quotes from the
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abstract and may be rephrased by the annotator. We
chose these sentences because of their rich variety of
miR-disease associations, which included relationships
between miRs and miR aspects (expression) and diseases
and disease aspects (outcome, biomarker, therapy), as
well as linking entities (target, process). Importantly, for
this study, we were not testing the ability of miRiaD to
detect appropriate sentences for EntrezGene annota-
tions; we were simply using the EntrezGene sentences as
a convenient source of the types of relations we designed
miRiaD to detect. The randomly chosen sentences men-
tioned both a miR and a disease but were both positive
and negative for miR-disease associations. The annota-
tors were asked to mark all the relations indicating a
miR-disease association, such we can assess miRiaD’s
ability to detect such relations.
We downloaded the GeneRIF sentences from the Entrez-
Gene database (ftp://ftp.ncbi.nih.gov/gene/GeneRIF). The
file contained a total of 946,742 entries at the time of down-
load (January 2015). Each entry in the downloaded file con-
tains a taxonomy ID, a gene ID, a PMID list, the GeneRIF
text, and the timestamp of the last update. Using the gene
ID field, we extracted all the entries where the gene ID was
that of a miR. Additionally, we looked in the GeneRIF text
of these entries for the mention of at least one disease using
the PubTator database [20] for the detection of disease
mentions. This resulted in a set of 8476 GeneRIF entries.
A set of 100 entries from all 8476 GeneRIF entries was
randomly selected and presented to a second annotator.
The annotator was asked to mark the GeneRIF sen-
tences as relevant if they contained a relationship be-
tween a miR and a disease mentioned within or not
relevant otherwise. Of the 100 sentences, 97 were
marked as relevant and 3 were marked as not relevant.
In addition, the annotator marked all of the relations in
the sentence indicating an association between a miR
and a disease, including miR and disease aspects and
linking entities. Because multiple miRs, diseases, and
types of relationships could be found within the same
sentence, the annotations yielded a total of 175 relations.
We also randomly selected a second set of 100 sen-
tences containing miR and disease mentions from Med-
line abstracts. As discussed earlier, the reason for
selecting an additional 100 sentences was to construct a
less biased evaluation set that included some negative
sentences. Ninety-two sentences were marked as rele-
vant and contained a total of 159 relations; 8 sentences
were marked as not relevant.
Study 3: Evaluation of the miRiaD sentence informativeness
ranking
Finally, we evaluated our informativeness ranking approach
using a set of sentences containing miR and disease men-
tions that were manually scored for informativeness by a
biologist. We selected 100 random sentences from the 8476
GeneRIF sentences that we obtained in the previous evalu-
ation, plus 100 sentences randomly selected from Medline
abstracts. We asked an annotator to mark each sentence
with scores on a three-point Likert scale, depending on
how “informative” the sentence might be to a researcher in-
terested in the disease, with a score of 1 indicating “some-
what informative”, a score of 2 indicating “informative”,
and a score of 3 indicating “highly informative”. The anno-
tator marked 58 sentences as “highly informative”, 87 sen-
tences as “informative”, and 55 sentences as “somewhat
informative”.
Results and Discussion
Study 1: Evaluation of miRiaD for assistance with manual
curation
miRiaD was applied to the sentences in 100 abstracts cited
by miR2Disease and 100 randomly selected Medline ab-
stracts (200 abstracts total) as described in Methods. The
results of this evaluation are shown in Table 1. For
the abstracts from miR2Disease, we obtained a recall
of 90 % (81 true positives (TP) and 9 false negatives
(FN)) for expression information and 89.6 % (52 TP
and 6 FN) for target information. For the randomly
selected abstracts, we got very similar results: recall
of 92.3 % for expression information and 83.3 % for
target information. When we combined the two sets
of abstracts, we obtained recalls of 90.78 % and
88.46 % for expression and target information re-
spectively. Using the randomly selected abstracts, we
were able to assess precision as well as recall. For ex-
pression information we obtained precision of 92.3 %
and f-score of 92.3 % (48 TP, 4 FN and 4 false posi-
tives (FP)); for target information we obtained preci-
sion of 97.5 % and f-score of 89.8 % for target
information (40 TP, 8 FN and 1 FP).
Looking at the false negatives, we observed that most
of the errors were introduced by highly complex sen-
tences, for which the iSimp tool could not generate use-
ful simplified sentences. As a result, the syntactic and
Table 1 Evaluation of miRiaD for assistance with manual curation
TP FN TN FP Recall Precision F-score
miR2Disease based set
Expression 81 9 - - 90.0 - -
Gene target 52 6 - - 89.6 - -
Randomly chosen set
Expression 48 4 46 4 92.3 92.3 92.3
Gene target 40 8 52 1 83.3 97.5 89.8
Combined
Expression 129 13 - - 90.78 - -
Gene target 92 14 - - 88.46 - -
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lexical patterns could not be matched. An example is the
following sentence: “Among 15 upregulated target genes
of the miR-30 miRNA, four genes known to be
expressed and/or functional in podocytes were identi-
fied, including receptor for advanced glycation end prod-
uct, vimentin, heat-shock protein 20, and immediate
early response 3” (PMID 18776119). The four genes were
not identified as targets of miR-30 due to the inability to
link them to the “four genes” mention, and subsequently
to the “15 upregulated target genes” mention. Another
class of false negatives involves relations missed due to the
presence of anaphora (generally a pronoun referring to an
entity). For example in the sentence fragment “…miR-
181a, a small non-coding RNA believed to induce apop-
tosis by repressing its target gene, BCL-2”, the word “its”
refers to “miR-181a”. We currently do not perform pro-
noun resolution and hence miRiaD misses the target rela-
tion with “BCL-2”. Looking at false positives, we observed
most of errors were introduced due incorrect identifica-
tion of the simplification constructs. In the sentence “the
protein inhibitor of activated STAT3 (PIAS3) was con-
firmed as a direct miR-21 target”, STAT3 was detected as
the parenthetical for PIAS3 and tagged as a target for
miR-21 in addition to PIAS3.
Study 2: Evaluation for general extraction of miR-disease
associations
For the second study, 100 GeneRIF sentences from
EntrezGene entries for miRNA and 100 sentences with
miR and disease mentions randomly chosen from Med-
line abstracts were processed by miRiaD (see Methods).
The results of this evaluation are shown in Table 2. miR-
iaD was able to identify relevant relations in 91 sen-
tences from the GeneRIF set and 93 sentences from the
Medline set. For calculation of TP, FN and FP we
matched the relations annotated by the annotators with
the relations extracted by miRiaD. This yielded recall of
84.0 %, precision of 94.8 %, and f-score of 89.1 % with
respect to GeneRIF sentences (147 TP, 28 FN and 8 FP)
and recall of 84.2 %, precision of 96.4 %, and f-score of
89.8 % with respect to the additional Medline sentences
(134 TP, 25 FN and 5 TP). As in the previous evaluation
we do not see a significant difference in performance
between the two evaluation sets. The combined f-score
for all 200 sentences was 89.4 %.
Looking at the false negatives in this evaluation re-
vealed an additional type of error. We observed certain
syntactic dependencies between events that should be
captured, but which are not. For example, the following
sentence contains a temporal relation, which is triggered
by the word “after”: “These data indicate for the first
time a mechanism involving STAT1/2 upregulation
under the transcriptional control of INF-alpha signaling
after knockdown of miR-221/222 cluster in U251 glioma
cells” (PMID 20428775). The relationship [miR-221/222,
negatively regulates, STAT1] could not be extracted
because of the system’s inability to detect the temporal
relation. As in or previous evaluation, we observed false
negatives due to anaphora. For example, in the sentence
fragment “…the tumor suppressor activity of miR-124
could be partly due to its inhibitory effects on glioma
stem-like traits and invasiveness…”, miRiaD misses the
inhibitory relations between “mir-124” and “stem-like
traits and invasiveness”.
Most of false positives errors in sentences had an in-
volvement relation between a miR and a disease in
addition to a more informative relation. For example in
the sentence “this study further extends the biological
role of miR-92b in non-small cell lung cancer A549 cells
and for the first time identifies PTEN as a novel target
of miR-92b”, miRiaD extracted an involvement relation
between miR-92b and “non-small cell lung cancer” that
was not marked as relevant by the annotator. Instead,
the annotator only marked the relation between “mir-
92b” and the target gene “PTEN” as relevant. This type
of errors will constitute the grounds for future work.
Study 3: Evaluation of the miRiaD sentence
informativeness ranking
This evaluation was conducted on 100 sentences ran-
domly selected from GeneRIF set used for the previous
evaluation 100 sentences randomly selected from Medline
abstracts, which were marked for their informativeness on
a three-point scale by an annotator (see Methods). miRiaD
ranked 57 sentences as “highly informative”, 97 sentences
as “informative”, and 48 sentences as “somewhat inform-
ative”. The comparisons between the annotator’s scores
and the miRiaD scores are shown in Table 3. Of the sen-
tences ranked as “highly informative” by the system, most
of them (45/57) were also ranked as “highly informative”
by the annotator; the remaining 12 sentences were ranked
as “informative” by the annotator. Looking at the diagonal
of the table, we observe that the majority of the scores in
all three categories were in agreement. The average score
difference on the 3-point scale (absolute value) between
annotator score and the miRiaD system score is 0.29.
Various correlation measures were computed, where a
value of 1 is total positive correlation, 0 is no correlation,
and −1 is total negative correlation. First, we computed
Table 2 Evaluation for general extraction of miR-disease
associations
TP FN TN FP Recall Precision F-score
GeneRIF based Set 147 28 1 8 84.0 94.8 89.1
Randomly chosen set 134 25 7 5 84.2 96.4 89.8
Combined 281 53 8 13 84.1 95.5 89.4
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the Pearson product-moment correlation coefficient,
which is widely used as a measure of the degree of linear
dependence between two variables (0.727). Second, we
computed the Kendall tau rank correlation coefficient,
which measures the association between two measured
quantities by looking at the similarity of the orderings of
the data when ranked by each of the quantities (0.678). Fi-
nally, we computed the Spearman’s rank correlation coef-
ficient, which assesses how well the relationship between
two variables can be described using a monotonic func-
tion, and got a value of 0.724, which indicates a “very
strong positive relationship” [35]. The p-values for these
correlation scores are very low, indicating that the null hy-
pothesis of no correlation is extremely unlikely. To test
against a stronger baseline than “no correlation”, we ran-
domly reordered the annotated scores 10,000 times and
calculated the Pearson correlation coefficient. The mean
correlation was 0.544, and none of the random correlation
values were above the reported correlation value 0.727.
We also computed the normalized discounted cumula-
tive gain (nDCG) [36, 37], which compares the ordering
of a list by a system (e.g., miRiaD) with the perfect or-
dering of that list by gold standard (e.g., our annotator).
Because the sentences were given scores between 1 and
3, and not actual ranks, multiple possible orderings are
possible when displaying the sentences marked with 3
first, then the sentences marked with 2 second, and
finally the sentences marked with 1 at the bottom. For
this reason, we considered 10,000 different possible or-
derings. The mean of the nDCGs scores obtained this
way was 0.977, with the lowest being 0.950 and the me-
dian being 0.978. The high nDCG values could be due
to the strong agreement between miRiaD and the anno-
tator for the sentences marked as “highly informative”.
Browsing the results online
We have developed a preliminary website for interactive
query of miRiaD miR-disease association extraction. The
interface accepts PubMed-like queries as input, thus
supporting queries like a miR name, or a disease name,
or any biological concept. For example, a user interested
in “miR-9” and “breast cancer” can submit a query such
as “mir-9” AND “breast cancer”. To ensure that all of the
abstracts passed to miRiaD contain a miR mention, we re-
strict the user query by appending the “AND” operator
and miRNA keywords connected by the “OR” operator,
i.e., query AND (miRNA[TIAB] OR microRNA[TIAB] OR
miR[TIAB]). The system then submits the query to
PubMed, which returns all the PMIDs satisfying the query.
miRiaD processes this list of PMIDs and displays the trip-
lets < miR,Disease,Text Evidence/PMID>. The interface is
available at the URL: http://biotm.cis.udel.edu/miRiaD.
Figure 3a–d provides screenshots of the interface.
Figure 3a. shows the search form where the user sub-
mits his/her query. Figure 3b. shows the triplet view in
the table after submitting the query “mir-9” AND
“breast cancer”. There are three columns in the triplet
view, namely: the miR, Disease and Text Evidence.
Note that the results also contains triplets for other
miR (mir-151, miR-200) and other diseases (hepatocel-
lular carcinoma, Hodgkin’s lymphoma etc.). This is due
to the fact that miRiaD processses the entire abstract
for each PMID returned by the submitted query and
some abstracts may contain mentions of multiple miR
and/or diseases. Results can be filtered to include only
those where mir-9 is the miR and breast cancer is the dis-
ease using the drop-down menus above each column as
shown in Fig. 3c. Finally, clicking on the PMID in the Text
Evidence column takes the user to the abstract (Fig. 3d.),
where sentences indicating the miR-disease association are
underlined and the respective miR’s and diseases are
highlighted in bold.
Browsing the highlighted sentences in the 13 PMIDs
shown in Fig. 3c reveals that miR-9 has been associated
with a number of breast cancer phenotypes including me-
tastasis, invasiveness, aggressiveness, cell motility, and
poor prognosis. miR-9 targeting of E-cadherin (CDH1)
has been implicated in promotion of cell motility and in-
vasiveness. Variations in miR-9 expression related to miR-
9 promoter hypermethylation have also been observed in
the disease. As a consequence of these findings, miR-9 has
been suggested as both a potential biomarker and thera-
peutic target. Interestingly, one study (PMID: 22761433)
reported that miR-9 targeting of the mitochondrial en-
zyme, MTHFD2, mediated a tumor suppressive effect in
breast cancer, and in contrast to other studies, found that
miR-9 inhibited invasion. More careful consideration of
the contextual information in these articles may help to
resolve this apparent contradiction. This small example il-
lustrates the wide variety of miRNA-disease information
that can be easily obtained using miRiaD.
Conclusion
In this paper, we have presented miRiaD, a relation ex-
traction system that automatically extracts associations
between miRs and diseases from the literature. The








Highly informative 45 12 0 57
Informative 11 64 20 97
Somewhat informative 2 11 35 48
Total 58 87 55 200
Row values correspond to the frequency of scores assigned by miRiaD, while
the columns denote the annotator score frequency
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miR-disease associations are sometimes indirect, with
miR and disease connected by a linking entity, such as a
target gene or cellular process. Similarly, miRs and dis-
eases might be mentioned in terms of their aspects:
(e.g., state or expression level for miRs or outcomes,
diagnostics/treatments, or therapy information for dis-
eases). Our method, which entails detecting syntactic
dependencies and, subsequently, semantic relations be-
tween miRs (or their aspects) and linking entities in the
context of a disease or disease aspect, has demonstrated
high performance (recall, precision, and F-scores) in
identifying information of interest to both database cu-
rators and biomedical researchers studying the connec-
tions between miRs and disease. Additionally, we have
shown how assigning scores to sentences containing a
miR-disease association, based on syntactic dependencies,
semantic relations, and linking entities, highly correlates
with preferences that biologists have in selecting the most
informative sentences for a miR-disease association. The
evaluation studies also pointed out some pitfalls of the
miRiaD system. Future work will include an expansion of
the syntactic dependencies, in conjunction with the iSimp
sentence simplifier, to detect multi-step causal events start-
ing from a miR and leading to its involvement in a disease.
We have provided an online interface for browsing the
results extracted from the entire Medline corpus, search-
able using PubMed queries. Our next steps will be focused
on full-scale processing of the PubMed Central (PMC)
Open-Access collection and enhancement of the miRiaD
on-line interface to allow for more complex querying of the
results. This work will enable researchers to address sophis-
ticated questions concerning the pathological roles of miRs,
such as (i) Are there miRs associated with metastasis across
multiple cancer types? (ii) Is there overlap in the sets of
genes targeted by miRs in different types of dementia? (iii)
Which miRs are associated with a better prognosis in pros-
tate cancer? (iv) For miRs that have been identified as pos-
sible therapeutic targets in breast cancer, what biological
processes do they regulate in a breast cancer context? (v) In
what diseases does miR regulation of apoptosis play a role?
Fig. 3 miRiaD Web Interface (http://biotm.cis.udel.edu/miRiaD). a Query interface. b Results of searching for “mir-9 AND breast cancer”. c Filtering
of search results to show those where the miR is mir-9 and the disease is breast cancer. d Text evidence view with miR and disease mentions
highlighted and miRiaD positive sentences underlined
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We plan to conduct specific biological use-case studies
aimed at some of these questions in the near future.
Additional file
Additional file 1: Formal description of the syntactic dependencies
patterns. A formal description of the patterns used in detection of
syntactic dependencies is provided in this file. In addition the list of
triggers used for determining semantic relation type and the types
semantic relations between the different entities is also provided in this
file. (PDF 83 kb)
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